JP2024521792A5 - - Google Patents
Info
- Publication number
- JP2024521792A5 JP2024521792A5 JP2023572828A JP2023572828A JP2024521792A5 JP 2024521792 A5 JP2024521792 A5 JP 2024521792A5 JP 2023572828 A JP2023572828 A JP 2023572828A JP 2023572828 A JP2023572828 A JP 2023572828A JP 2024521792 A5 JP2024521792 A5 JP 2024521792A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163193573P | 2021-05-26 | 2021-05-26 | |
| US63/193,573 | 2021-05-26 | ||
| PCT/US2022/031115 WO2022251484A1 (en) | 2021-05-26 | 2022-05-26 | Treatment of complement-mediated disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024521792A JP2024521792A (ja) | 2024-06-04 |
| JP2024521792A5 true JP2024521792A5 (https=) | 2025-06-02 |
| JPWO2022251484A5 JPWO2022251484A5 (https=) | 2025-06-02 |
Family
ID=84229204
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023572828A Pending JP2024521792A (ja) | 2021-05-26 | 2022-05-26 | 補体媒介性疾患の治療法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20250002910A1 (https=) |
| EP (1) | EP4346844A4 (https=) |
| JP (1) | JP2024521792A (https=) |
| WO (1) | WO2022251484A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11510939B1 (en) | 2019-04-19 | 2022-11-29 | Apellis Pharmaceuticals, Inc. | RNAs for complement inhibition |
| WO2022226127A1 (en) * | 2021-04-20 | 2022-10-27 | Alexion Pharmaceuticals, Inc. | Compositions and methods for inhibiting complement component 3 expression |
| CN120265773A (zh) * | 2022-10-14 | 2025-07-04 | 美国圣因生物股份有限公司 | 靶向c3的小干扰rna及其用途 |
| EP4600358A1 (en) * | 2023-04-14 | 2025-08-13 | Rigerna Therapeutics (Suzhou) Co., Ltd. | Compound for inhibiting c3 gene expression, pharmaceutical composition and use thereof |
| AU2024312039A1 (en) * | 2023-06-21 | 2026-01-22 | Changzhou Hansoh Pharmaceutical Co., Ltd. | Sirna, conjugate which contain sirna, pharmaceutical composition and uses thereof |
| CN117050998B (zh) * | 2023-08-25 | 2024-02-09 | 青岛农业大学 | 一种miRNA在防治溴氰虫酰胺抗性烟粉虱中的应用 |
| JPWO2025143000A1 (https=) * | 2023-12-27 | 2025-07-03 | ||
| WO2025168134A1 (zh) * | 2024-02-08 | 2025-08-14 | 北京安龙生物医药有限公司 | 靶向补体成分c3基因的寡核苷酸及其用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2019113301A (ru) * | 2016-10-17 | 2020-11-17 | Апеллис Фармасьютикалс, Инк. | Комбинированная терапия для ингибирования с3 |
| AU2018360697A1 (en) * | 2017-11-01 | 2020-05-14 | Alnylam Pharmaceuticals, Inc. | Complement component C3 iRNA compositions and methods of use thereof |
-
2022
- 2022-05-26 WO PCT/US2022/031115 patent/WO2022251484A1/en not_active Ceased
- 2022-05-26 EP EP22812151.3A patent/EP4346844A4/en active Pending
- 2022-05-26 US US18/563,184 patent/US20250002910A1/en active Pending
- 2022-05-26 JP JP2023572828A patent/JP2024521792A/ja active Pending